Q&A With Lee Helman, MD, on New Cancer Targets and Therapeutics

Helman_Photo_external

The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses what to expect this year, and peers into the future of targeted cancer therapies and immunotherapy.

Read More